Delivering Drugs to Tubular Cells and Organelles: The Application of Nanodrugs in Acute Kidney Injury

References

• Abebe A , KumelaK, BelayM, KebedeB, WobieY. Mortality and predictors of acute kidney injury in adults: a hospital-based prospective observational study. Sci. Rep.11(1), 15672 (2021).
   PubMed Web of Science ®Google Scholar
• Kellum JA , RomagnaniP, AshuntantangG, RoncoC, ZarbockA, AndersHJ. Acute kidney injury. Nat. Rev. Dis. Primers7(1), 52 (2021).
   PubMed Web of Science ®Google Scholar
• Ronco C , BellomoR, KellumJA. Acute kidney injury. Lancet394(10212), 1949–1964 (2019).
   PubMed Web of Science ®Google Scholar
• Hukriede NA , SorannoDE, SanderVet al. Experimental models of acute kidney injury for translational research. Nat. Rev. Nephrol.18(5), 277–293 (2022).
   PubMed Web of Science ®Google Scholar
• Kuwabara S , GogginsE, OkusaMD. The pathophysiology of sepsis-associated AKI. Clin. J. Am. Soc. Nephrol.17(7), 1050–1069 (2022).
   PubMed Web of Science ®Google Scholar
• Park SJ , LiC, ChenYM. Endoplasmic reticulum calcium homeostasis in kidney disease: pathogenesis and therapeutic targets. Am. J. Pathol.191(2), 256–265 (2021).
   PubMed Web of Science ®Google Scholar
• Lankadeva YR , MayCN, BellomoR, EvansRG. Role of perioperative hypotension in postoperative acute kidney injury: a narrative review. Br. J. Anaesth.128(6), 931–948 (2022).
   PubMed Web of Science ®Google Scholar
• Perazella MA , RosnerMH. Drug-induced acute kidney injury. Clin. J. Am. Soc. Nephrol.17(8), 1220–1233 (2022).
   PubMed Web of Science ®Google Scholar
• Liu BC , TangTT, LvLL, LanHY. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int.93(3), 568–579 (2018).
   PubMed Web of Science ®Google Scholar
• Li Z , LiuZ, LuoMet al. The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury. Cell Death Discov.8(1), 239 (2022).
   PubMed Web of Science ®Google Scholar
• Jourde-Chiche N , FakhouriF, DouLet al. Endothelium structure and function in kidney health and disease. Nat. Rev. Nephrol.15(2), 87–108 (2019).
   PubMed Web of Science ®Google Scholar
• Molema G , ZijlstraJG, van MeursM, KampsJ. Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury. Nat. Rev. Nephrol.18(2), 95–112 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang K , LiR, ChenXet al. Renal endothelial cell-targeted extracellular vesicles protect the kidney from ischemic injury. Adv. Sci. (Weinh.)10(3), e2204626 (2023).
   PubMedGoogle Scholar
• Wang S , WangY, LaiXet al. Minimalist nanocomplex with dual regulation of endothelial function and inflammation for targeted therapy of inflammatory vascular diseases. ACS Nano17(3), 2761–2781 (2023).
   PubMed Web of Science ®Google Scholar
• Oroojalian F , CharbgooF, HashemiMet al. Recent advances in nanotechnology-based drug delivery systems for the kidney. J. Control. Rel.321, 442–462 (2020).
   PubMed Web of Science ®Google Scholar
• Geo HN , MuruganDD, ChikZet al. Renal nano-drug delivery for acute kidney Injury: current status and future perspectives. J. Control. Rel.343, 237–254 (2022).
   PubMed Web of Science ®Google Scholar
• Kamaly N , HeJC, AusielloDA, FarokhzadOC. Nanomedicines for renal disease: current status and future applications. Nat. Rev. Nephrol.12(12), 738–753 (2016).
   PubMed Web of Science ®Google Scholar
• Kamada H , TsutsumiY, Sato-KamadaKet al. Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting. Nat. Biotechnol.21(4), 399–404 (2003).
   PubMed Web of Science ®Google Scholar
• Wei H , JiangD, YuBet al. Nanostructured polyvinylpyrrolidone–curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury. Bioact. Mater.19, 282–291 (2023).
   PubMed Web of Science ®Google Scholar
• Zhu Z , LiuX, LiPet al. Renal clearable quantum dot–drug conjugates modulate labile iron species and scavenge free radicals for attenuating chemotherapeutic drug-induced acute kidney injury. ACS Appl. Mater. Interfaces15(18), 21854–21865 (2023).
   PubMed Web of Science ®Google Scholar
• Duan R , LiY, ZhangRet al. Reversing acute kidney injury through coordinated interplay of anti-inflammation and iron supplementation. Adv. Mater.35(28), e2301283 (2023).
   PubMed Web of Science ®Google Scholar
• Li Y , WangG, WangTet al. PEGylated gambogic acid nanoparticles enable efficient renal-targeted treatment of acute kidney injury. Nano Lett.23(12), 5641–5656 (2023).
   PubMed Web of Science ®Google Scholar
• Alidori S , AkhaveinN, ThorekDLet al. Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci. Transl. Med.8(331), 331ra339 (2016).
   Web of Science ®Google Scholar
• Yan R , CuiW, MaW, LiJ, LiuZ, LinY. Typhaneoside–tetrahedral framework nucleic acids system: mitochondrial recovery and antioxidation for acute kidney injury treatment. ACS Nano17(9), 8767–8781 (2023).
   PubMed Web of Science ®Google Scholar
• Choi HS , MathewAP, UthamanSet al. Inflammation-sensing catalase-mimicking nanozymes alleviate acute kidney injury via reversing local oxidative stress. J. Nanobiotechnol.20(1), 205 (2022).
   PubMed Web of Science ®Google Scholar
• Wang S , ChenY, HanSet al. Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway. Theranostics12(8), 3882–3895 (2022).
   PubMed Web of Science ®Google Scholar
• Jiang D , GeZ, ImHJet al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat. Biomed. Eng.2(11), 865–877 (2018).
   PubMed Web of Science ®Google Scholar
• Williams RM , ShahJ, MercerEet al. Kidney-targeted redox scavenger therapy prevents cisplatin-induced acute kidney injury. Front. Pharmacol.12, 790913 (2021).
   PubMed Web of Science ®Google Scholar
• Han SJ , WilliamsRM, D’AgatiV, JaimesEA, HellerDA, LeeHT. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney Int.98(1), 76–87 (2020).
   PubMed Web of Science ®Google Scholar
• Vallorz EL , JandaJ, MansourHM, SchnellmannRG. Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice. Kidney Int.102(5), 1073–1089 (2022).
   PubMed Web of Science ®Google Scholar
• Deng X , ZengT, LiJet al. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Biomater. Sci.7(12), 5312–5323 (2019).
   PubMed Web of Science ®Google Scholar
• Nurunnabi M , KhatunZ, HuhKMet al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano7(8), 6858–6867 (2013).
   PubMed Web of Science ®Google Scholar
• Wang H , YuD, FangJet al. Phenol-like group functionalized graphene quantum dots structurally mimicking natural antioxidants for highly efficient acute kidney injury treatment. Chem. Sci.11(47), 12721–12730 (2020).
   PubMed Web of Science ®Google Scholar
• Yu H , LinT, ChenWet al. Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis. Biomaterials219, 119368 (2019).
   PubMed Web of Science ®Google Scholar
• Leeuwis JW , NguyenTQ, DendoovenA, KokRJ, GoldschmedingR. Targeting podocyte-associated diseases. Adv. Drug Deliv. Rev.62(14), 1325–1336 (2010).
   PubMed Web of Science ®Google Scholar
• Williams RM , ShahJ, NgBDet al. Mesoscale nanoparticles selectively target the renal proximal tubule epithelium. Nano Lett.15(4), 2358–2364 (2015).
   PubMed Web of Science ®Google Scholar
• Aird WC . Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res.100(2), 174–190 (2007).
   PubMed Web of Science ®Google Scholar
• Brenner BM , TroyJL, DaughartyTM. On the mechanism of inhibition in fluid reabsorption by the renal proximal tubule of the volume-expanded rat. J. Clin. Invest.50(8), 1596–1602 (1971).
   PubMed Web of Science ®Google Scholar
• Williams RM , ShahJ, TianHSet al. Selective nanoparticle targeting of the renal tubules. Hypertension71(1), 87–94 (2018).
   PubMed Web of Science ®Google Scholar
• Vallorz EL , Blohm-MangoneK, SchnellmannRG, MansourHM. Formoterol PLGA-PEG nanoparticles induce mitochondrial biogenesis in renal proximal tubules. AAPS J.23(4), 88 (2021).
   PubMed Web of Science ®Google Scholar
• Otsuka H , NagasakiY, KataokaK. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev.55(3), 403–419 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang F , LiuMR, WanHT. Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol. Pharm. Bull.37(3), 335–339 (2014).
   PubMed Web of Science ®Google Scholar
• Christensen EI , BirnH, StormT, WeyerK, NielsenR. Endocytic receptors in the renal proximal tubule. Physiology27(4), 223–236 (2012).
   PubMed Web of Science ®Google Scholar
• Qin S , WuB, GongT, ZhangZR, FuY. Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury. J. Control. Rel.349, 401–412 (2022).
   PubMed Web of Science ®Google Scholar
• Pang M , DuanS, ZhaoMet al. Co-delivery of celastrol and lutein with pH sensitive nano micelles for treating acute kidney injury. Toxicol. Appl. Pharmacol.450, 116155 (2022).
   PubMed Web of Science ®Google Scholar
• Matsuura S , KatsumiH, SuzukiHet al. L-serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier. Proc. Natl Acad. Sci. USA115(41), 10511–10516 (2018).
   PubMed Web of Science ®Google Scholar
• Knight SF , KunduK, JosephGet al. Folate receptor-targeted antioxidant therapy ameliorates renal ischemia–reperfusion injury. J. Am. Soc. Nephrol.23(5), 793–800 (2012).
   PubMed Web of Science ®Google Scholar
• Huang C , ZengT, LiJet al. Folate receptor-mediated renal-targeting nanoplatform for the specific delivery of triptolide to treat renal ischemia/reperfusion injury. ACS Biomater. Sci. Eng.5(6), 2877–2886 (2019).
   PubMed Web of Science ®Google Scholar
• Du B , ZhaoM, WangYet al. Folic acid-targeted pluronic F127 micelles improve oxidative stress and inhibit fibrosis for increasing AKI efficacy. Eur. J. Pharmacol.930, 175131 (2022).
   PubMed Web of Science ®Google Scholar
• Hu JB , LiSJ, KangXQet al. CD44-targeted hyaluronic acid–curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydr. Polym.193, 268–280 (2018).
   PubMed Web of Science ®Google Scholar
• Huang ZW , ShiY, ZhaiYYet al. Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury. J. Control. Rel.334, 275–289 (2021).
   PubMed Web of Science ®Google Scholar
• Walkon LL , Strubbe-RiveraJO, BazilJN. Calcium overload and mitochondrial metabolism. Biomolecules12(12), 1891 (2022).
   PubMed Web of Science ®Google Scholar
• Liu D , ShuG, JinFet al. ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Sci. Adv.6(41), eabb7422 (2020).
   PubMed Web of Science ®Google Scholar
• Li J , DuanQ, WeiX, WuJ, YangQ. Kidney-targeted nanoparticles loaded with the natural antioxidant rosmarinic acid for acute kidney injury treatment. Small18(48), e2204388 (2022).
   PubMed Web of Science ®Google Scholar
• Tang TT , WangB, LiZLet al. KIM-1 targeted extracellular vesicles: a new therapeutic platform for RNAi to treat AKI. J. Am. Soc. Nephrol.32(10), 2467–2483 (2021).
   PubMed Web of Science ®Google Scholar
• Yan J , WangY, ZhangJ, LiuX, YuL, HeZ. Rapidly blocking the calcium overload/ROS production feedback loop to alleviate acute kidney injury via microenvironment-responsive BAPTA-AM/BAC co-delivery nanosystem. Small19(17), e2206936 (2023).
   PubMed Web of Science ®Google Scholar
• Huang Z , ChunC, LiX. Kidney targeting peptide-modified biomimetic nanoplatforms for treatment of acute kidney injury. J. Control. Rel.358, 368–381 (2023).
   PubMed Web of Science ®Google Scholar
• Liu Z , LiuX, YangQ, YuL, ChangY, QuM. Neutrophil membrane-enveloped nanoparticles for the amelioration of renal ischemia–reperfusion injury in mice. Acta Biomater.104, 158–166 (2020).
   PubMed Web of Science ®Google Scholar
• Tang TT , WangB, WuMet al. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci. Adv.6(33), eaaz0748 (2020).
   PubMed Web of Science ®Google Scholar
• Gatti S , BrunoS, DeregibusMCet al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia–reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant.26(5), 1474–1483 (2011).
   PubMed Web of Science ®Google Scholar
• Zhao M , LiuS, WangCet al. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA. ACS Nano15(1), 1519–1538 (2021).
   PubMed Web of Science ®Google Scholar
• Cao H , ChengY, GaoHet al. In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia–reperfusion injury. ACS Nano14(4), 4014–4026 (2020).
   PubMed Web of Science ®Google Scholar
• Yuan ZX , ZhangZR, ZhuDet al. Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan. Mol. Pharm.6(1), 305–314 (2009).
   PubMedGoogle Scholar
• Wang DW , LiSJ, TanXYet al. Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury. Carbohydr. Polym.256, 117556 (2021).
   PubMed Web of Science ®Google Scholar
• Kaunitz JD , CumminsVP, MishlerD, NagamiGT. Inhibition of gentamicin uptake into cultured mouse proximal tubule epithelial cells by L-lysine. J. Clin. Pharmacol.33(1), 63–69 (1993).
   PubMed Web of Science ®Google Scholar
• Wischnjow A , SarkoD, JanzerMet al. Renal targeting: peptide-based drug delivery to proximal tubule cells. Bioconjug. Chem.27(4), 1050–1057 (2016).
   PubMed Web of Science ®Google Scholar
• Wang J , PoonC, ChinDet al. Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery. Nano Res.11(10), 5584–5595 (2018).
   Web of Science ®Google Scholar
• Schreiber A , TheiligF, SchwedaF, HocherlK. Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney. Kidney Int.82(1), 53–59 (2012).
   PubMed Web of Science ®Google Scholar
• Wu X , TangS, DaiQet al. Vitamin D–vitamin D receptor alleviates oxidative stress in ischemic acute kidney injury via upregulating glutathione peroxidase 3. FASEB J.37(2), e22738 (2023).
   PubMed Web of Science ®Google Scholar
• Wang S , HuangS, LiuX, HeY, LiuY. Paricalcitol ameliorates acute kidney injury in mice by suppressing oxidative stress and inflammation via Nrf2/HO-1 signaling. Int. J. Mol. Sci.24(2), 969 (2023).
   PubMed Web of Science ®Google Scholar
• Du J , JiangS, HuZet al. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis. Am. J. Physiol. Renal Physiol.316(5), F1068–F1077 (2019).
   PubMed Web of Science ®Google Scholar
• Siegelman MH , DegrendeleHC, EstessP. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol.66(2), 315–321 (1999).
   PubMed Web of Science ®Google Scholar
• Lewington AJ , PadanilamBJ, MartinDR, HammermanMR. Expression of CD44 in kidney after acute ischemic injury in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.278(1), R247–254 (2000).
   PubMed Web of Science ®Google Scholar
• Fu Z , FanQ, ZhouY, ZhaoY, HeZ. Elimination of intracellular calcium overload by BAPTA-AM-loaded liposomes: a promising therapeutic agent for acute liver failure. ACS Appl. Mater. Interfaces11(43), 39574–39585 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Y , PuM, YanJet al. 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid acetoxymethyl ester loaded reactive oxygen species responsive hyaluronic acid–bilirubin nanoparticles for acute kidney injury therapy via alleviating calcium overload mediated endoplasmic reticulum stress. ACS Nano17(1), 472–491 (2023).
   PubMed Web of Science ®Google Scholar
• Cichy J , PureE. The liberation of CD44. J. Cell Biol.161(5), 839–843 (2003).
   PubMed Web of Science ®Google Scholar
• Ichimura T , BonventreJV, BaillyVet al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem.273(7), 4135–4142 (1998).
   PubMed Web of Science ®Google Scholar
• Arai S , KitadaK, YamazakiTet al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat. Med.22(2), 183–193 (2016).
   PubMed Web of Science ®Google Scholar
• Han WK , BaillyV, AbichandaniR, ThadhaniR, BonventreJV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int.62(1), 237–244 (2002).
   PubMed Web of Science ®Google Scholar
• Ichimura T , AsseldonkEJPV, HumphreysBD, GunaratnamL, DuffieldJS, BonventreJV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest.118(5), 1657–1668 (2008).
   PubMed Web of Science ®Google Scholar
• Freeman GJ , CasasnovasJM, UmetsuDT, DekruyffRH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev.235, 172–189 (2010).
   PubMed Web of Science ®Google Scholar
• Kong L , FanD, ZhouL, WeiS. The influence of modified molecular (D/L-serine) chirality on the theragnostics of PAMAM-based nanomedicine for acute kidney injury. J. Mater. Chem. B9(43), 9023–9030 (2021).
   PubMed Web of Science ®Google Scholar
• Luk BT , ZhangL. Cell membrane-camouflaged nanoparticles for drug delivery. J. Control. Rel.220(Pt B), 600–607 (2015).
   PubMed Web of Science ®Google Scholar
• Chen L , HongW, RenW, XuT, QianZ, HeZ. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct. Target. Ther.6(1), 225 (2021).
   PubMed Web of Science ®Google Scholar
• Jin K , LuoZ, ZhangB, PangZ. Biomimetic nanoparticles for inflammation targeting. Acta Pharm. Sin. B8(1), 23–33 (2018).
   PubMed Web of Science ®Google Scholar
• Deng J , KohdaY, ChiaoHet al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int.60(6), 2118–2128 (2001).
   PubMed Web of Science ®Google Scholar
• Ouyang W , O’GarraA. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity50(4), 871–891 (2019).
   PubMed Web of Science ®Google Scholar
• Karp JM , TeolGSL. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell4(3), 206–216 (2009).
   PubMed Web of Science ®Google Scholar
• Bruno S , GrangeC, DeregibusMCet al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol.20(5), 1053–1067 (2009).
   PubMed Web of Science ®Google Scholar
• Cheng YQ , YueYX, CaoHMet al. Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy. J. Nanobiotechnol.19(1), 451 (2021).
   PubMed Web of Science ®Google Scholar
• Li Y , WangJ, WientjesMG, AuJL. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv. Drug Deliv. Rev.64(1), 29–39 (2012).
   PubMed Web of Science ®Google Scholar
• Tang C , CaiJ, YinXM, WeinbergJM, VenkatachalamMA, DongZ. Mitochondrial quality control in kidney injury and repair. Nat. Rev. Nephrol.17(5), 299–318 (2021).
   PubMed Web of Science ®Google Scholar
• Liu Z , LiY, LiC, YuL, ChangY, QuM. Delivery of coenzyme Q10 with mitochondria-targeted nanocarrier attenuates renal ischemia–reperfusion injury in mice. Mater. Sci. Eng. C Mater. Biol. Appl.131, 112536 (2021).
   PubMed Web of Science ®Google Scholar
• Yu H , JinF, LiuDet al. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics10(5), 2342–2357 (2020).
   PubMed Web of Science ®Google Scholar
• Qin S , LiuC, ChenYet al. Cobaltosic oxide–polyethylene glycol–triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney Int.103(5), 903–916 (2023).
   PubMed Web of Science ®Google Scholar
• Liu D , JinF, ShuGet al. Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes. Biomaterials211, 57–67 (2019).
   PubMed Web of Science ®Google Scholar
• Huang Q , YangY, ZhaoTet al. Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment. Bioact. Mater.21, 381–393 (2023).
   PubMed Web of Science ®Google Scholar
• Smith RA , PorteousCM, CoulterCV, MurphyMP. Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem.263(3), 709–716 (1999).
   PubMedGoogle Scholar
• Murphy MP , SmithRA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Ann. Rev. Pharmacol. Toxicol.47, 629–656 (2007).
   PubMed Web of Science ®Google Scholar
• Reily C , MitchellT, ChackoBK, BenavidesGA, MurphyMP, Darley-UsmarVM. Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol.1(1), 86–93 (2013).
   PubMed Web of Science ®Google Scholar
• Battogtokh G , ChoiYS, KangDSet al. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Acta Pharm. Sin. B8(6), 862–880 (2018).
   PubMed Web of Science ®Google Scholar
• Zhao K , ZhaoGM, WuDet al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem.279(33), 34682–34690 (2004).
   PubMed Web of Science ®Google Scholar
• Birk AV , LiuS, SoongYet al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J. Am. Soc. Nephrol.24(8), 1250–1261 (2013).
   PubMed Web of Science ®Google Scholar
• Szeto HH . First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br. J. Pharmacol.171(8), 2029–2050 (2014).
   PubMed Web of Science ®Google Scholar
• Kumar S . Cellular and molecular pathways of renal repair after acute kidney injury. Kidney Int.93(1), 27–40 (2018).
   PubMed Web of Science ®Google Scholar
• Ruggiero A , VillaCH, BanderEet al. Paradoxical glomerular filtration of carbon nanotubes. Proc. Natl Acad. Sci. USA107(27), 12369–12374 (2010).
   PubMed Web of Science ®Google Scholar
• Ma X , GongN, ZhongL, SunJ, LiangXJ. Future of nanotherapeutics: targeting the cellular sub-organelles. Biomaterials97, 10–21 (2016).
   PubMed Web of Science ®Google Scholar
• Ledford H . ‘Astonishing’ molecular syringe ferries proteins into human cells. Nature616(7955), 18–19 (2023).
   PubMed Web of Science ®Google Scholar
• Kreitz J , FriedrichMJ, GuruAet al. Programmable protein delivery with a bacterial contractile injection system. Nature616(7956), 357–364 (2023).
   PubMed Web of Science ®Google Scholar
• Hulse M , RosnerMH. Drugs in development for acute kidney injury. Drugs79(8), 811–821 (2019).
   PubMed Web of Science ®Google Scholar
• Fouad AA , Al-MulhimAS, JresatI. Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats. Life Sci.91(7–8), 284–292 (2012).
   PubMed Web of Science ®Google Scholar
• Kanlaya R , ThongboonkerdV. Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases. Adv. Nutr.10(1), 112–121 (2019).
   PubMed Web of Science ®Google Scholar
• Li HD , MengXM, HuangC, ZhangL, LvXW, LiJ. Application of herbal traditional Chinese medicine in the treatment of acute kidney injury. Front. Pharmacol.10, 376 (2019).
   PubMed Web of Science ®Google Scholar